Novavax, Inc.

Historical 13F Holders

Symbol
NVAX
CUSIP
670002401
All holders as of
Q2 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 293 106 M $667 M
2025 Q1 281 98.5 M $632 M
2024 Q4 270 103 M $825 M
2024 Q3 277 93.8 M $1.17 B
2024 Q2 276 85.3 M $1.08 B
2024 Q1 239 80.5 M $389 M
2023 Q4 241 85.8 M $415 M
2023 Q3 264 61.9 M $402 M
2023 Q2 253 66.5 M $381 M
2023 Q1 261 60.0 M $416 M
2022 Q4 296 58.7 M $602 M
2022 Q3 294 36.2 M $660 M
2022 Q2 375 34.0 M $1.75 B
2022 Q1 431 33.5 M $2.48 B
2021 Q4 487 35.0 M $5.00 B
2021 Q3 498 37.5 M $7.76 B
2021 Q2 464 39.8 M $8.44 B
2021 Q1 431 42.5 M $7.70 B
2020 Q4 388 40.3 M $4.52 B
2020 Q3 351 32.4 M $3.51 B
2020 Q2 240 31.8 M $2.84 B
2020 Q1 139 13.2 M $179 M
2019 Q4 93 7.05 M $28.2 M
2019 Q3 94 7.03 M $35.4 M
2019 Q2 94 6.73 M $39.6 M
2019 Q1 4 4.36 M $2.53 M
2016 Q3 1 1.00 k $2.08 k
2016 Q2 1 1.00 k $7.27 k